Teva Sees Off Emergent’s US Narcan Appeal In ‘A Close Case’

‘We Are A Court Of Review, Not A Court Of First Resort,’ Federal Circuit Underlines

twin targets
Teva hit the target in both rulings • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Legal & IP

More from Generics Bulletin